Loading...
01/11 03:36
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals several concerning factors: declining NAV, lower NII, increased expenses, and unclear management responses. The Q&A highlights potential risks with Soli Organic and uncertainty in dividend payouts. Despite some positive aspects like portfolio growth and high yields, these are overshadowed by negative elements, leading to a negative sentiment.
Net Investment Income (NII) $0.27 per share, unchanged from Q4 2024, down from $0.38 per share in Q1 2024 due to lower interest and fee income on the debt investment portfolio.
Debt Portfolio Growth Increased by $20 million during Q1 2025, reflecting new investments despite macroeconomic headwinds.
Debt Portfolio Yield 15% for Q1 2025, down from 15.6% in Q1 2024, but remains among the highest in the BDC industry.
Onboarding Yields 13% for Q1 2025, up from 12.6% in Q4 2024, indicating strong performance in new loan originations.
Total Investment Portfolio $690 million as of March 31, 2025, up from $678 million as of December 31, 2024.
Total Expenses $13.4 million for Q1 2025, compared to $13.1 million in Q1 2024, primarily due to increased interest expenses.
Interest Expense $8.7 million for Q1 2025, up from $8.2 million in Q1 2024, due to an increase in average borrowings.
NAV (Net Asset Value) $7.57 per share as of March 31, 2025, down from $8.43 as of December 31, 2024, and $9.64 as of March 31, 2024, primarily due to adjustments in fair value and paid distributions.
Undistributed Spillover Income $1 per share as of March 31, 2025.
Committed and Approved Backlog $236 million as of March 31, 2025, up from $207 million at the end of Q4 2024.
New Debt Investments: In Q1 2025, Horizon funded nine debt investments totaling $100 million, including $31 million to three new portfolio companies in life science and technology markets.
Equity Investments: Two equity investments totaling $2 million were made during the first quarter.
Portfolio Growth: The debt portfolio grew by $20 million during the first quarter.
Market Conditions: The venture capital ecosystem is facing challenges due to macroeconomic factors, including tariff-related uncertainties, impacting recovery from stressed assets.
Venture Capital Investment: Approximately $92 billion was invested in VC-backed companies in Q1 2025, a 19% increase from Q4 2024.
Exit Market: The exit market remains relatively closed, with significant investor pullback in the life science market due to tariff uncertainties.
Net Investment Income: Net investment income for Q1 2025 was $0.27 per share, consistent with Q4 2024.
Portfolio Yield: The debt portfolio yield was 15%, one of the highest in the BDC industry.
Liquidity Position: As of March 31, 2025, Horizon had $126 million in available liquidity.
Advisor Fee Waiver: The advisor agreed to waive a portion of its quarterly income incentive fees to align interests with shareholders.
Partnership with Wendel Group: Monroe Capital, owner of Horizon's advisor, partnered with Wendel Group, enhancing capital and scale.
Macro Environment Risks: The macro environment, including tariff-related uncertainty, has dampened optimism and directly impacted potential recovery from stressed assets, leading to a decrease in NAV.
Venture Capital Market Risks: The venture capital ecosystem is unlikely to return to a positive path due to worldwide market volatility, which poses challenges for the company's growth.
Regulatory Risks: Uncertainty related to policy announcements regarding increasing tariffs on pharmaceuticals and decreased NIH and FDA funding is causing significant investor pullback in the life science market.
Exit Market Risks: The exit markets for VC-backed tech and life science companies remain nearly shut, making it challenging for VCs to return capital to their limited partners.
Portfolio Performance Risks: Negative portfolio events, including downgrades of investments in InBrace and Standvast due to lack of exit markets and broader macro volatility, have impacted fair values.
Economic Factors: Continued volatility in equity markets is causing investors and M&A acquirers to remain on the sidelines, which could further pressure the VC ecosystem.
Portfolio Growth: Horizon aims to grow its portfolio in future quarters, with a goal to deliver net investment income (NII) at or above declared distributions over time.
Investment Capacity: The company increased its investment capacity by raising equity from its at-the-market program and closing an increase in the commitment amount of its New York Life credit facility.
Backlog Growth: Horizon increased its committed and approved backlog to nearly $236 million, providing a solid base for future portfolio growth.
Advisor Fee Waiver: The advisor has agreed to waive a portion of its quarterly income incentive fees to align interests with shareholders.
Partnership with Wendel Group: Monroe Capital's partnership with Wendel Group is expected to provide additional capital and scale for Horizon.
Monthly Distributions: The Board declared regular monthly distributions of $0.11 per share through September 2025.
Net Investment Income Outlook: Horizon expects to generate strong NII over time, supported by high portfolio yields and a growing pipeline of investment opportunities.
NAV Projection: The NAV as of March 31 was $7.57 per share, down from $8.43 at the end of 2024, primarily due to fair value adjustments.
Debt Portfolio Yield: The debt portfolio yield for the quarter was 15%, one of the highest in the BDC industry, with expectations to maintain strong yields.
Investment Capacity: As of March 31, potential new investment capacity was $307 million, indicating strong liquidity and growth potential.
Monthly Distributions: The Board declared regular monthly distributions of $0.11 per share through September 2025.
Undistributed Spillover Income: The company's undistributed spillover income as of March 31 was $1 per share.
Incentive Fee Waiver: The advisor has agreed to waive a portion of its quarterly income incentive fees if the company's net investment income for the quarter would be less than the distributions declared.
The earnings call summary indicates strong financial performance with increased investment income and reduced expenses. The merger with Monroe Capital Corporation is expected to provide significant capital infusion, cost savings, and portfolio diversification, enhancing Horizon's market position. Although there were some unclear management responses, the overall sentiment from the Q&A was positive, with expectations for leverage targets to be met soon and sustainable yields. The strategic plan and financial health suggest a positive stock price movement in the short term.
The earnings call summary provides a mixed outlook with both positive and negative elements. The partnership with Wendel Group and increased investment capacity are positive, but the decline in NAV and potential operational cost savings not materializing are concerning. The Q&A section reveals some uncertainties, particularly in management's lack of specific targets and plans. The merger provides a premium to MRCC shareholders and is cost-efficient for Horizon, but there are risks in portfolio diversification. Overall, the sentiment is neutral, reflecting balanced positive and negative factors with no clear catalyst for significant stock movement.
The earnings call reveals several concerning factors: declining NAV, lower NII, increased expenses, and unclear management responses. The Q&A highlights potential risks with Soli Organic and uncertainty in dividend payouts. Despite some positive aspects like portfolio growth and high yields, these are overshadowed by negative elements, leading to a negative sentiment.
The earnings call reflects several concerns: declining NAV and portfolio yield, lower investment income, increased expenses, and ongoing risks in the venture capital ecosystem. Although there is a strategic partnership with Wendel Group and regular distributions, the uncertainties in investment exits and regulatory challenges overshadow positives. The Q&A section revealed unclear management responses and concerns about certain portfolio companies. Additionally, the drop in NAV and portfolio yield, along with increased interest expenses, are significant negatives that outweigh the positives, likely leading to a negative stock price reaction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
